KRM Ayurveda Ltd. (KRMAYURVED-SM): KRM Ayurveda Share Price rises 8.7% to Rs 293.5 today
- August 26, 2026
- Posted by: Harsh Piplani
- Category: News
KRM Ayurveda Share Price rose to Rs 293.5 today, up 8.7% from the previous close of Rs 270, while the company’s market capitalisation stands at Rs 574.04 crore. The move places KRM Ayurveda Ltd. in today’s stock news flow as a notable share price rise, but the supplied data does not establish a company-specific catalyst. What the numbers do show is a full-day advance from an open of Rs 270 to a session high of Rs 293.5, with turnover of Rs 2.7 crore and a healthcare valuation profile that is well above the industry median on P/B and notably below the industry median on P/E. Investors tracking KRM Ayurveda Share Price Today can focus on valuation, profitability, sector comparison and the next company update rather than assuming a reason that is not verified.
KRM Ayurveda Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 293.5 |
| Previous Close | Rs 270 |
| Today's Move | Rs 23.5 (+8.7%) |
| Open | Rs 270 |
| High | Rs 293.5 |
| Low | Rs 270 |
| Turnover | Rs 2.7 crore |
| Market Capitalisation | Rs 574.04 crore |
| Market Cap Category | Micro Cap |
KRM Ayurveda Ltd. (KRMAYURVED-SM) rose to Rs 293.5 from the previous close of Rs 270, a move of Rs 23.5 or 8.7%. The stock opened at Rs 270, reached a high of Rs 293.5, recorded a low of Rs 270.
KRM Ayurveda Share Price Today reflects a clean same-day rise: the stock opened at Rs 270, matched the day’s low at Rs 270, and closed the available session data at Rs 293.5, which is also the day’s high. The gain of Rs 23.5 translates into an 8.7% move versus the previous close of Rs 270. This is a straightforward price rise in the share price, and the supplied data confirms the event without attaching an unverified cause. In market-news language, KRM Ayurveda stock is among the names rising today, but the verified record is limited to the price move, the day range and turnover. For readers following KRM Ayurveda Stock News or KRM Ayurveda Share News, the key fact is that the move was session-wide rather than a late-day spike.
KRM Ayurveda Ltd. (KRMAYURVED-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 574.04 crore |
| P/E Ratio | 28.53x |
| P/B Ratio | 10.62x |
| ROE | 67.86% |
| ROCE | 41.83% |
| EPS | Rs 9.46 |
| Book Value Per Share | Rs 25.43 |
| Dividend Yield | 0% |
KRM Ayurveda Ltd. (KRMAYURVED-SM) fundamental metrics show P/E 28.53x, P/B 10.62x, ROE 67.86%, ROCE 41.83%. These figures provide context only and are not a buy or sell signal.
KRM Ayurveda Ltd. has a market capitalisation of Rs 574.04 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.53x, P/B at 10.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 67.86% and ROCE of 41.83%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 9.46, book value per share of Rs 25.43, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 46.21x, median ROE of 12.82%, median ROCE of 14.97%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 28.53x |
| Benchmark Median P/E | 46.21x |
| Benchmark Average P/E | 104.15x |
| Benchmark P/E Range | 7.86x to 1,577.75x |
| Company P/B Ratio | 10.62x |
| Benchmark Median P/B | 4.22x |
| Company ROE | 67.86% |
| Benchmark Median ROE | 12.82% |
| Company ROCE | 41.83% |
| Benchmark Median ROCE | 14.97% |
| Company Market Capitalisation | Rs 574.04 crore |
| Benchmark Median Market Cap | Rs 701 crore |
KRM Ayurveda Ltd. (KRMAYURVED-SM) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
KRM Ayurveda Ltd. (KRMAYURVED-SM) has a P/E ratio of 28.53x, which is below the benchmark median of 46.21x, a difference of -38.26%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
KRM Ayurveda Ltd. (KRMAYURVED-SM) has a ROE of 67.86%, which is above the benchmark median of 12.82%, a difference of +429.33%. KRM Ayurveda Ltd. (KRMAYURVED-SM) has a ROCE of 41.83%, which is above the benchmark median of 14.97%, a difference of +179.43%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP | 1,25,092.65 | 61.09 | 13.18 | 23.54 | 21.73 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 97,429.99 | 112.89 | 5.52 | 12.95 | 13.93 |
| Max Healthcare Institute Ltd. | MAXHEALTH | 96,169.45 | 67.81 | 9.04 | 14.53 | 14.97 |
| Fortis Healthcare Ltd. | FORTIS | 69,218.34 | 66.4 | 6.85 | 11.32 | 14.07 |
| Aster DM Healthcare Ltd. | ASTERDM | 65,427.73 | 209.44 | 13.44 | 9.32 | 11.46 |
KRM Ayurveda Ltd. (KRMAYURVED-SM) has a P/E ratio of 28.53x compared with the displayed peer median of 67.81x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 67.86% compares with a peer median of 12.95% across the companies shown in the table. ROCE stood at 41.83% versus the displayed peer median of 14.07%, providing a capital-efficiency comparison. KRM Ayurveda Ltd. (KRMAYURVED-SM) has a market capitalisation of Rs 574.04 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching KRM Ayurveda
- KRM Ayurveda Share Price rose 8.7% today to Rs 293.5 from Rs 270.
- The stock closed at the day’s high of Rs 293.5 after opening at Rs 270.
- Market capitalisation stands at Rs 574.04 crore, which frames the current KRM Ayurveda Share Price Today move.
- P/E is 28.53 and P/B is 10.62, giving the price rise a clear valuation context.
- ROE of 67.86% and ROCE of 41.83% are both well above the sector benchmark medians.
About KRM Ayurveda
KRM Ayurveda Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. Based on the supplied market data, the company is being tracked alongside listed healthcare names rather than as a general market story. The article’s available data does not include a business-segment breakdown, revenue mix or product list, so the most reliable company description comes from its sector classification and financial profile. For readers of KRM Ayurveda Share Price coverage, that means the stock should be understood in the context of healthcare services, where earnings quality, return ratios and valuation multiples often shape how the market interprets each move. Univest presents this company-level view together with price data so that KRM Ayurveda Share Price Today can be read alongside fundamentals, sector benchmarks and peer comparisons rather than in isolation.
Track KRM Ayurveda Share Price on Univest
Use KRM Ayurveda Ltd. (KRMAYURVED-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track KRM Ayurveda Share Price live on Univest for price updates, stock news, financial ratios, shareholding pattern, 52-week levels and market insights. Univest also helps compare KRM Ayurveda Stock News with healthcare peers, sector benchmarks and company fundamentals in one place. For anyone following KRM Ayurveda Share Price Today, this keeps the analysis connected to both the day’s move and the broader stock performance context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did KRM Ayurveda Share Price rise today?
Ans. The verified data confirms that KRM Ayurveda Share Price rose 8.7% today, but it does not establish a company-specific catalyst. The move is visible through the day’s open, high, low and previous close.
What is KRM Ayurveda Share Price today?
Ans. KRM Ayurveda Share Price today is Rs 293.5. That is Rs 23.5 above the previous close of Rs 270 and represents an 8.7% gain in the latest session data supplied.
What is KRM Ayurveda market cap?
Ans. KRM Ayurveda’s market capitalisation is Rs 574.04 crore. This places the company below the industry median market cap in the supplied healthcare benchmark and provides size context for the latest share price rise.
How does KRM Ayurveda compare with healthcare peers?
Ans. KRM Ayurveda’s P/E of 28.53 is below the supplied healthcare peer set, while its ROE of 67.86% and ROCE of 41.83% are above the listed peer values. That creates a mixed valuation profile.
What do KRM Ayurveda’s P/E and P/B show?
Ans. KRM Ayurveda’s P/E is 28.53 and P/B is 10.62. The P/E sits below the industry median, while the P/B is above the industry median, so the stock trades with a mixed valuation picture.
What do EPS and book value mean for KRM Ayurveda?
Ans. EPS is Rs 9.46 and book value is Rs 25.43. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share at the current point in time.
Is there a dividend yield for KRM Ayurveda Share Price?
Ans. The supplied dividend yield is 0. That means no current yield is shown in the data, so the latest KRM Ayurveda Share Price view is better read through earnings, book value and peer ratios.
Where does KRM Ayurveda stand in its sector?
Ans. KRM Ayurveda is in Healthcare, within Hospital & Healthcare Services. In the supplied same-industry benchmark, its P/E is below the median, while ROE and ROCE are above the benchmark medians.
